Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia
Inge van der Sluis,
Anja Möricke,
Gabriele Escherich,
Arend von Stackelberg,
Wolfgang Holter,
Thomas Klingebiel,
Christian Flotho,
Sabine Legien,
Wim Tissing,
Marc Bierings,
Cecile Guimbal-Schmolck,
Uwe Pichlmeier,
Hans-Jürgen Kühnel,
Rob Pieters
Affiliations
Inge van der Sluis
Department of Pediatric Oncology and Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
Anja Möricke
Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Germany
Gabriele Escherich
University Medical Center Eppendorf, Clinic of Pediatric Hematology/Oncology, Hamburg, Germany
Arend von Stackelberg
Department of Pediatric Oncology/Hematology, Charité University Hospital Berlin, Germany
Wolfgang Holter
Pediatric Hematology and Oncology, University Hospital Erlangen, Germany
Thomas Klingebiel
Hospital for Children and Adolescents II/III, University Hospital Frankfurt, Germany
Christian Flotho
Division of Pediatric Hematology/Oncology, Department of Pediatric and Adolescent Medicine, University of Freiburg, Germany
